Ligand Pharmaceuticals (LGND) Treasury Shares (2010 - 2026)
Ligand Pharmaceuticals (LGND) reported Treasury Shares of $42.3 million for Q4 2013, little changed on a YoY basis from $42.3 million in Q4 2012, and little changed sequentially from $42.3 million in Q3 2013.
Ligand Pharmaceuticals (LGND) Treasury Shares (2010 - 2026) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 4 years of Treasury Shares data on file, last reported at $42.3 million in Q4 2013.
- For the quarter ending Q4 2013, Treasury Shares changed 0.0% year-over-year to $42.3 million; the trailing twelve-month figure through Dec 2013 stood at $42.3 million (changed 0.0% YoY), and the FY2013 full-year result was $42.3 million, changed 0.0% from the prior year.
- Treasury Shares held at $42.3 million in Q4 2013, from $42.3 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $512361.0 in Q2 2024 to a low of $162152.0 in Q1 2022.
- A 5-year average of $406604.4 and a median of $437872.0 in 2024 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares increased 0.13% in 2011 and changed 0.0% in 2012, its largest moves.
- Tracing LGND's Treasury Shares over 4 years: stood at $42.2 million in 2010, then climbed by 0.13% to $42.3 million in 2011, then changed by 0.0% to $42.3 million in 2012, then changed by 0.0% to $42.3 million in 2013.
- Business Quant data shows LGND's Treasury Shares at $42.3 million in Q4 2013, $42.3 million in Q3 2013, and $42.3 million in Q2 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn | 439,789.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 439,789.00 |
| Mar 31, 2026 | 439,789.00 |
| Dec 31, 2025 | 455,547.00 |
| Dec 31, 2025 | 455,547.00 |
| Sep 30, 2025 | 459,213.00 |
| Sep 30, 2025 | 459,213.00 |
| Jun 30, 2025 | 462,834.00 |
| Jun 30, 2025 | 462,834.00 |
| Mar 31, 2025 | 468,003.00 |
| Mar 31, 2025 | 468,003.00 |
| Dec 31, 2024 | 437,872.00 |
| Dec 31, 2024 | 437,872.00 |
| Sep 30, 2024 | 499,830.00 |
| Sep 30, 2024 | 499,830.00 |
| Jun 30, 2024 | 512,361.00 |
| Jun 30, 2024 | 512,361.00 |
| Mar 31, 2024 | 497,099.00 |
| Mar 31, 2024 | 497,099.00 |
| Dec 31, 2023 | 350,905.00 |
| Dec 31, 2023 | 350,905.00 |